Top

Clinical Neuroradiology

Published in:

01-12-2018 | Original Article

Bioresorbable Vascular Scaffolds in Interventional Neuroradiology

Authors: Anil Arat, Ergun Daglioglu, Ilkay Akmangit, Ahmet Peker, Murat Arsava, Mehmet Akif Topcuoglu, Deniz Belen

Published in: Clinical Neuroradiology | Issue 4/2018

Abstract

Purpose

Bioresorbable vascular scaffolds (BVS) have changed practice patterns in cardiology. These resorbable stents have not yet been utilized in the cerebrovascular circulation. We report the initial experiences with these devices in interventional neuroradiology.

Methods

A retrospective review of clinical presentations, imaging findings and follow-up results of all patients treated using a BVS by our neurovascular team was carried out using hospital electronic charts and the hospital radiographic archive system. Treatment was performed only if patients had a non-tortuous cerebrovascular anatomy suitable for navigation by the bulky BVS.

Results

In this study 9 patients (5 women, mean age 51.3 years) were treated with Absorb or DeSolve scaffolds without permanent morbidity or mortality, 5 had intracranial or vertebral artery stenosis and in 4 patients with cerebral aneurysms scaffold-assisted coiling was performed. At a mean follow-up of 22.3 months, 1 parent artery in the aneurysm group was occluded and the remaining BVSs showed no significant restenosis. Fusiform luminal enlargement was demonstrated in one aneurysm patient. In two patients treated for stenosis, transient intra-arterial filling defects resembling BVS struts (scaffold silhouette) was demonstrated on early follow-up angiograms. In the patient with parent artery occlusion (who was judged to have unjailed the internal carotid bifurcation) and in the patient with luminal remodeling, we were able to discontinue all antiplatelet medications at 3 years without any consequences.

Conclusion

Absorbable stent technology has potential applications in interventional neuroradiology. We suggest that BVS should be optimized for cerebral circulation if prospective studies are to be undertaken for cerebrovascular applications of BVS.

Available only for authorised users

Tenekecioglu E, Farooq V, Bourantas CV, Silva RC, Onuma Y, Yılmaz M, Serruys PW. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention. BMC Cardiovasc Disord. 2016;16:38.CrossRefPubMedPubMedCentral

Byrne RA, Kastrati A. Disappearing scaffolds, dissolving expectations. Lancet. 2016;388(10059):2451–2.CrossRefPubMed

Wang K, Yuan S, Zhang X, Liu Q, Zhong Q, Zhang R, Lu P, Li J. Biodegradable flow-diverting device for the treatment of intracranial aneurysm: short-term results of a rabbit experiment. Neuroradiology. 2013;55(5):621–8.CrossRefPubMed

Schellhammer F, Berlis A, Bloss H, Pagenstecher A, Schumacher M. Poly-lactic-acid coating for endovascular stents. Preliminary results in canine experimental arteriovenous fistulae. Invest Radiol. 1997;32(3):180–6.CrossRef

Wang J, An Q, Li D, Wu T, Chen W, Sun B, El-Hamshary H, Al-Deyab SS, Zhu W, Mo X. Heparin and vascular endothelial growth factor loaded poly(L-lactide-co-caprolactone) nanofiber covered stent-graft for aneurysm treatment. J Biomed Nanotechnol. 2015;11(11):1947–60.CrossRef

Wang JB, Zhou B, Gu XL, Li MH, Gu BX, Wang W, Li YD. Treatment of a canine carotid artery aneurysm model with a biodegradable nanofiber-covered stent: a prospective pilot study. Neurol India. 2013;61(3):282–7.CrossRefPubMed

Aoun RJ, Sattur MG, Panchanathan RS, Bendok BR. The ABSORB III trial: potential new concepts for intracranial atherosclerosis in the post-SAMMPRIS era. Neurosurgery. 2016;78(2):N19–N20.CrossRefPubMed

He D, Liu W, Zhang T. The development of carotid stent material. Interv Neurol. 2015;3(2):67–77.CrossRefPubMed

Indolfi C, De Rosa S, Colombo A. Bioresorbable vascular scaffolds – basic concepts and clinical outcome. Nat Rev Cardiol. 2016;13(12):719–29.CrossRefPubMed

10.

Kereiakes DJ, Onuma Y, Serruys PW, Stone GW. Bioresorbable vascular scaffolds for coronary revascularization. Circulation. 2016;134(2):168–82.CrossRefPubMed

11.

Deloose K, Bosiers M, Callaert J. TVR Reduction in the SFA. Endovascular today. 2014 October

12.

Strandberg E, Zeltinger J, Schulz DG, Kaluza GL. Late positive remodeling and late lumen gain contribute to vascular restoration by a non-drug eluting bioresorbable scaffold: a four-year intravascular ultrasound study in normal porcine coronary arteries. Circ Cardiovasc Interv. 2012;5(1):39–46.CrossRefPubMed

13.

Bontinck J, Goverde P, Schroe H, Hendriks J, Maene L, Vermassen F. Treatment of the femoropopliteal artery with the bioresorbable remedy stent. J Vasc Surg. 2016;64(5):1311–9.CrossRefPubMed

14.

Kaya T, Daglioglu E, Gurkas E, Akmangit I, Peker A, Belen D, Dede D, Elhan AH, Arat A. Silk device for the treatment of Intracranial aneurysms, part 2: factors related to clinical and angiographic outcome. Turk Neurosurg. 2016;26(4):533–7.CrossRefPubMed

15.

Charpentier E, Barna A, Guillevin L, Juliard JM. Fully bioresorbable drug-eluting coronary scaffolds: a review. Arch Cardiovasc Dis. 2015;108(6):385–97.CrossRefPubMed

16.

Picard F, L’Allier PL, Tanguay JF. Early multiple coronary micro aneurysms after bioresorbable vascular scaffold implantation. Can J Cardiol. 2016;33(2):292.e9–292.e11.CrossRef

17.

Cook S, Meier P. Bioresorbable vascular scaffold: promises and the fallen child-as-king? Open Heart. 2016;3(2):e000527.CrossRefPubMedPubMedCentral

18.

Collet C, de Winter RJ, Onuma Y, Serruys PW. The Absorb bioresorbable vascular scaffold for the treatment of coronary artery disease. Expert Opin Drug Deliv. 2016;13(10):1489–99.CrossRefPubMed

19.

Mukete BN, van der Heijden LC, Tandjung K, Baydoun H, Yadav K, Saleh QA, Doggen CJ, Abi Rafeh N, Le Jemtel TH, von Birgelen C. Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1‑year follow-up: A systematic review and meta-analysis of studies. Int J Cardiol. 2016;221:1087–94.CrossRefPubMed

20.

Serruys PW, Ormiston J, van Geuns RJ, de Bruyne B, Dudek D, Christiansen E, Chevalier B, Smits P, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Wasungu L, Ediebah D, Veldhof S, Onuma Y. A polylactide bioresorbable scaffold eluting everolimus for treatment of coronary stenosis: 5‑year follow-up. J Am Coll Cardiol. 2016;67(7):766–76.CrossRefPubMed

21.

Giordano A, Messina S, Biondi-Zoccai G. Successful treatment of a subclavian artery stenosis with a coronary bioresorbable vascular scaffold. J Endovasc Ther. 2016;23(4):653–6.CrossRefPubMed

22.

Giordano A, Ferraro P, Corcione N, Messina S, Maresca G, Coscioni E, Biondi-Zoccai G. Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: a case report. Int J Surg Case Rep. 2016;21:78–82.CrossRefPubMedPubMedCentral

23.

Park JB, Bronzino JD. Biomaterials: principles and applications. Boca Raton: CRC Press; 2002.CrossRef

24.

Wang Y. New biomaterials derived from poly (lactic acids): novel approaches to combine biodegradation, x‑ray contrast and controlled local drug release. Maastricht: Maastricht University; 2015.

25.

McDougall CG, Johnston SC, Gholkar A, Barnwell SL, Vazquez Suarez JC, Massó Romero J, Chaloupka JC, Bonafe A, Wakhloo AK, Tampieri D, Dowd CF, Fox AJ, Imm SJ, Carroll K, Turk AS; MAPS Investigators. Bioactive versus bare platinum coils in the treatment of intracranial aneurysms: the MAPS (Matrix and Platinum Science) trial. AJNR Am J Neuroradiol. 2014;35(5):935–42.CrossRefPubMed

26.

Molyneux AJ, Clarke A, Sneade M, Mehta Z, Coley S, Roy D, Kallmes DF, Fox AJ. Cerecyte coil trial: angiographic outcomes of a prospective randomized trial comparing endovascular coiling of cerebral aneurysms with either cerecyte or bare platinum coils. Stroke. 2012;43(10):2544–50.CrossRefPubMed

27.

Cuellar H, Guimaraens L, Ambekar S, Vivas E, Theron J. Angioseal as a hemostatic device for direct carotid puncture during endovascular procedures. Interv Neuroradiol. 2015;21(2):273–6.CrossRefPubMedPubMedCentral

28.

Gasbarro V, Traina L, Mascoli F, Coscia V, Buffone G, Grande R, Fugetto F, Butrico L, de Franciscis S, Serra R. Absorbable suture material in carotid surgery. Vasa. 2015;44(6):451–7.CrossRefPubMed

29.

Levy EI, Hanel RA, Howington JU, Nemes B, Boulos AS, Tio FO, Paciorek AM, Amlani S, Kagan-Hallett KS, Fronckowiak MD, Guterman LR, Hopkins LN. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg. 2004;100(4):688–94.CrossRefPubMed

30.

Levy EI, Hanel RA, Tio FO, Garlick DS, Bailey L, Cunningham MR, Williard C, Sherman D, Dooley JF, Kopia GA. Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180 day assessment. Neurosurgery. 2006;59(4):925–33, discussion 933–4.CrossRefPubMed

31.

Arat A, Diaz O, Strother C, Klucznik R. Comparison of drug eluting-balloon expandable and self expandable stents for stenting of intracranial atherosclerosis. Interv Neuroradiol. 2009;15(Suppl 1):97.

32.

Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37(10):2562–6.CrossRefPubMed

33.

Park S, Lee DG, Chung WJ, Lee DH, Suh DC. Long-term outcomes of drug-eluting stents in symptomatic Intracranial stenosis. Neurointervention. 2013;8(1):9–14.CrossRefPubMedPubMedCentral

34.

Natarajan SK, Ogilvy CS, Hopkins LN, Siddiqui AH, Levy EI. Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis. J Neurointerv Surg. 2010;2(2):104–9.CrossRefPubMed

35.

Costa JR Jr, Abizaid A, Feres F, Costa R, Seixas AC, Maia F, Abizaid A, Tanajura LF, Staico R, Siqueira D, Meredith L, Bhat V, Yan J, Ormiston J, Sousa AG, Fitzgerald P, Sousa JE. Excella First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions. EuroIntervention. 2008;4(1):53–8.CrossRef

36.

Zhang F, Qian J, Dong L, Ge J. Coronary aneurysm formation following biodegradable polymer drug-eluting stent implantation. Int J Cardiol. 2012;160(1):e8–e9.CrossRefPubMed

37.

Karanasos A, Garcia-Garcia HM, van Geuns RJ, Regar E. Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations. JACC Cardiovasc Interv. 2015;8(3):e53–e4.CrossRefPubMed

38.

Abizaid A, Ribamar Costa J Jr, Bartorelli AL, Whitbourn R, van Geuns RJ, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong WF, Sudhir K, Serruys PW; ABSORB EXTEND investigators. The absorb extend study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention. 2015;10(12):1396–401.CrossRefPubMed

39.

Lafont A, Durand E. A.R.T.: concept of a bioresorbable stent without drug elution. EuroIntervention. 2009;5(Suppl F):F83–F7.CrossRefPubMed

40.

Butteriss D, Gholkar A, Mitra D, Birchall D, Jayakrishnan V. Single-center experience of cerecyte coils in the treatment of intracranial aneurysms: initial experience and early follow-up results. AJNR Am J Neuroradiol. 2008;29(1):53–6.CrossRefPubMed

41.

Ramot Y, Haim-Zada M, Domb AJ, Nyska A. Biocompatibility and safety of PLA and its copolymers. Adv Drug Deliv Rev. 2016;107:153–62.CrossRefPubMed

42.

Collet C, Serruys PW. Polymer biodegradation kinetics: Do they matter? J Am Coll Cardiol. 2016;67(19):2259–62.CrossRefPubMed

43.

Rudolph A, Teske M, Illner S, Kiefel V, Sternberg K, Grabow N, Wree A, Hovakimyan M. Surface modification of biodegradable polymers towards better biocompatibility and lower thrombogenicity. PLoS One. 2015;10(12):e0142075.CrossRefPubMedPubMedCentral

44.

Kono K, Terada T. Feasibility of insertion of a microcatheter through a Y-stent in coil embolization of cerebral aneurysms and its detailed geometry by micro-computed tomography. Acta Neurochir (Wien). 2014;156(1):39–43.CrossRef

45.

Topcuoglu OM, Akgul E, Daglioglu E, Topcuoglu ED, Peker A, Akmangit I, Belen D, Arat A. Flow diversion in middle cerebral artery aneurysms: Is it really an all-purpose treatment? World Neurosurg. 2016;87:317–27.CrossRefPubMed

Title: Bioresorbable Vascular Scaffolds in Interventional Neuroradiology
Authors: Anil Arat
Ergun Daglioglu
Ilkay Akmangit
Ahmet Peker
Murat Arsava
Mehmet Akif Topcuoglu
Deniz Belen
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: Clinical Neuroradiology / Issue 4/2018
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI: https://doi.org/10.1007/s00062-017-0609-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Bioresorbable Vascular Scaffolds in Interventional Neuroradiology

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2018

In-stent Stenosis after p64 Flow Diverter Treatment

Longitudinal Volume Quantification of Deep Medullary Veins in Patients with Cerebral Venous Sinus Thrombosis

A New Classification System is Helpful in Diagnosing Intracranial Complications of Acute Mastoiditis in CT

Clinical Significance of Circumferential Aneurysmal Wall Enhancement in Symptomatic Patients with Unruptured Intracranial Aneurysms: a High-resolution MRI Study

Retrieval of Migrated Volume Coils Using Different Clot Retrievers in a Porcine Model

Superficial Siderosis and Dural Ectasia in a Patient with Marfan Syndrome